Strategy Asset Managers LLC
- SEC CIK
- 0001166716
- Latest filing
- Aug 14, 2026
INDP holding history
Indaptus Therapeutics, Inc. in every 13F filed by Strategy Asset Managers LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
INDP overviewAll 13F holders of INDPFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −45,336−100.0% | Sold out | Holders |
| Q1 2025 | 45,336 | $24.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 45,336 | $38.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 45,336 | $56.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 45,336 | $86.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 45,336 | $101.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 45,336 | $79.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 45,336 | $124.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 45,336 | $86.6K | <0.1% | −10,000−18.1% | Reduced | Holders |
| Q1 2023 | 55,336 | $102.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 55,336 | $80.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 55,336 | $120.0K | <0.1% | +55,336 | New | Holders |